Bavencio 200 mg/10 mL (20 mg/mL) injection Images

Generic Name: avelumab

This medication has been identified as Bavencio 200 mg/10 mL (20 mg/mL) injection. It is supplied by EMD Serono, Inc.

Bavencio is used in the treatment of Merkel Cell Carcinoma; Urothelial Carcinoma; Renal Cell Carcinoma and belongs to the drug class anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors). Bavencio 200 mg/10 mL (20 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Bavencio

Generic Name

avelumab

Strength

200 mg/10 mL (20 mg/mL) injection

Availability

Prescription only

Drug Class

Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)

CSA Schedule

Not a controlled drug

Labeler / Supplier

EMD Serono, Inc.

National Drug Code (NDC)

44087-3535

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer